E D Bird|L L Iversen - JoVE Visualize

Showing results (151-160 of 208) with videos related to

Pageof 21

Sort By:

Neuroscience Letters|October 5, 1987

Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouseA J Stoessl, C T Dourish, S C Young, et al.

Science (New York, N.Y.)|July 19, 1985

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, V T Tran, et al.

Annals of Neurology|March 1, 1986

Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer typeE B Fishman, G C Siek, R D MacCallum, et al.

Neuroscience Letters|January 2, 1986

Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's diseaseN L Foster, C A Tamminga, T L O'Donohue, et al.

Neurology|July 1, 1991

Morphometric analysis of the prefrontal cortex in Huntington's diseaseA Sotrel, P A Paskevich, D K Kiely, et al.

Alzheimer Disease and Associated Disorders|January 1, 1987

Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer diseaseW Bondareff, C Q Mountjoy, M Roth, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complexJ A Kemp, A C Foster, P D Leeson, et al.

Brain Research|December 16, 1982

Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's diseaseM N Rossor, S P Hunt, L L Iversen, et al.

Archives of General Psychiatry|September 1, 1982

Increased brain dopamine and dopamine receptors in schizophreniaA V Mackay, L L Iversen, M Rossor, et al.

Neuroscience|March 1, 1995

Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's diseaseQ Huang, D Zhou, E Sapp, et al.

Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:

Pageof 21

Neuroscience Letters|October 5, 1987

Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouseA J Stoessl, C T Dourish, S C Young, et al.

Science (New York, N.Y.)|July 19, 1985

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, V T Tran, et al.

Annals of Neurology|March 1, 1986

Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer typeE B Fishman, G C Siek, R D MacCallum, et al.

Neuroscience Letters|January 2, 1986

Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's diseaseN L Foster, C A Tamminga, T L O'Donohue, et al.

Neurology|July 1, 1991

Morphometric analysis of the prefrontal cortex in Huntington's diseaseA Sotrel, P A Paskevich, D K Kiely, et al.

Alzheimer Disease and Associated Disorders|January 1, 1987

Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer diseaseW Bondareff, C Q Mountjoy, M Roth, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complexJ A Kemp, A C Foster, P D Leeson, et al.

Brain Research|December 16, 1982

Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's diseaseM N Rossor, S P Hunt, L L Iversen, et al.

Archives of General Psychiatry|September 1, 1982

Increased brain dopamine and dopamine receptors in schizophreniaA V Mackay, L L Iversen, M Rossor, et al.

Neuroscience|March 1, 1995

Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's diseaseQ Huang, D Zhou, E Sapp, et al.

Pageof 21